Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CTRU vs. ARKG: which is better?

Bottom line

CTRU vs ARKG: the short answer

CTRU (ARK Transparency ETF) and ARKG (ARK Genomic Revolution ETF) are both etfs.

Updated Nov 19, 2026

CTRU vs ARKG side by side

CTRUARKG
TypeETFETF
Fund familyARK InvestARK Invest
CategoryOtherHealth Care Sector
Expense ratio—0.75%
Annual cost per $10k—$75
10-yr cost on $10k (prospectus)—$930
Max front loadNoneNone
12b-1 fee—0%
1-yr return—−28.1%
5-yr return (annualized)—−6.5%
10-yr return (annualized)—+1.9%
Best quarter—+66.0%
Worst quarter—−31.5%
Net assets (fund)—$1.6B
Number of holdings—33
Portfolio turnover—33%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CTRU and ARKG share none of their top holdings.

CTRU top 10

    ARKG top 10

    1. 10x Genomics Inc — 9.39%
    2. Twist Bioscience Corp — 7.73%
    3. Tempus Ai Inc — 6.56%
    4. Crispr Therapeutics Ag — 6.29%
    5. Personalis Inc — 5.47%
    6. Absci Corp — 5.14%
    7. Guardant Health Inc — 4.74%
    8. Illumina Inc — 4.74%
    9. Eli Lilly & Company — 4.68%
    10. Caredx Inc — 4.30%

    FAQ

    What is the difference between CTRU and ARKG?
    CTRU (ARK Transparency ETF) and ARKG (ARK Genomic Revolution ETF) are both etfs.
    Should I own both CTRU and ARKG?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.